Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica

Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica

Objectives Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are overlapping autoinflammatory diseases affecting people over 50 years. The diseases are treated with immunosuppressive drugs such as prednisolone, methotrexate, leflunomide and tocilizumab. In this study, we assessed the immun...

Full description

Bibliographic Details
Main Authors: Elisabeth Brouwer, Kornelis S M van der Geest, Maria Sandovici, Yannick van Sleen, Janneke H Terpstra, Marieke van der Heiden, Debbie van Baarle, Rosanne D Reitsema, Idil Esen, Elisabeth Raveling-Eelsing, Thomas Lieber, Annemarie M Buisman
Format: Article
Language:English
Published: BMJ Publishing Group 2022-09-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/2/e002479.full

Internet

https://rmdopen.bmj.com/content/8/2/e002479.full

Similar Items